GlassScriptPhysician profile
Amanda K Kramer
NPI 1407131915
$755.32
in general payments reported to CMS, 2019-2025
11 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $133 · 2024: $448 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $148.74 | 2023-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $145.51 | 2024-2025 | Rybelsus, Ozempic |
| Abbvie INC. | $145.47 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $102.88 | 2024 | Voquezna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $68.20 | 2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $38.64 | 2024 | Rexulti |
| Lilly USA, LLC | $33.17 | 2024 | Jardiance, Zepbound, Mounjaro |
| Amgen INC. | $32.11 | 2024 | Prolia, Evenity, Otezla |
| Paratek Pharmaceuticals, INC. | $14.11 | 2024 | Nuzyra |
| Novartis Pharmaceuticals Corporation | $13.46 | 2024 | |
| Exact Sciences Corporation | $13.03 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.